Trans-membrane peptide therapy for malignant glioma by use of a peptide derived from the MDM2 binding site of p53
Journal of Neuro-Oncology,

Yamada S et al. – The results suggest that this protein–transduction method using the p53–nuclear localization sequence (NLS)–laminin (Ln)–11R peptide may become a promising glioma therapy as an alternative gene therapy.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Internal Medicine

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Internal Medicine Articles

Indexed Journals in Internal Medicine: New England Journal of Medicine, The Lancet, Archives of Internal Medicinemore